page_banner

Products

2,3,5-Triphenyl-2H-tetrazolium chloridum Cas: 298-96-4 98% Off-album / pallide flavo pulveris crystallini

Description:

Catalogue Number: XD90154
Cas: 298-96-4
Formulae hypotheticae: C19H15N4·Cl
Pondus hypotheticum: 334.80
Availability: In Stock
Pretium:  
Prepack: 5g USD10
Mole Pack: Request Quote

 

 

 

 

 

 

 


Product Detail

Product Tags

Catalogue Number XD90154
Product Name 2,3,5-Triphenyl-2H-tetrazolium chloridum
CAS 298-96-4
Formulae hypotheticae C19H15N4·Cl
M. Pondus 334.80
Repono Details 2 ad 8 °C
Tariff Code harmonized 29339980

 

Product Specification

Aspectus Off-album / luteum crystallinum pulveris
Assay Min.98%
Liquescens punctum 235 - 245 Deg C
Damnum in Siccatio <3.0%
Aqua Content 0.5% Max
Residere in Ignition Maximilianus.0.5%
Solubilitas in EtoH Transi
Solubilitas in Ethanol Patet et completum

 

 

Ad investigandum effectum commodi conjunctionis butyrati, Lactobacillus casei, et L-carnitini in rat colitis exemplar. Rats in septem circulos divisae sunt.Quattuor circulos oralem butyratam, L-carnitinam, Lactobacillum casei et tres agentes compositum per X dies continuos receperunt.Reliqui coetus negativa et positiva moderamina et simulacrum coetus comprehenderunt.Examinationes macroscopicae, histopathologicae, et biomarkes ut tumor necrosis factor-alpha (TNF-α) et interlukin-1β (IL-1β), myeloperoxidase (MPO), acidum thiobarbituricum substantias reactivas (TBARS), et ferricum facultatem plasmatis redactam (FRAP. ) in colonia constituta erant. Coniunctio therapiae significantem effectum commodi praebuit in levatione colitis ad imperium comparatum.Overall changes in reduction of TNF-α (114.66 ± 18.26 vs 171.78 ± 9.48 pg/mg interdum, P < 0.05), IL-1β (24.9 ± 1.07 vs 33.06 ± 2.16 pg/mg interdum, P < 0.05), TBARS (0.2 MPO (15.32 ± 0.4 vs 27.24 ± 3.84 U/mg interdum, P < 0.05), et elevatio FRAP (23.46 ± 1.2 vs 15.02 ± 2.37 μmol/L , P < 0.05) praelationem coniunctionis therapiae in comparatione ad controllata.Quamquam monotherapia etiam efficax in colitis figmentorum emendatione, coniunctio therapia multo melior erat in emendatione notarum oxidativarum colonorum incluso FRAP, TBARS, et MPO. Praesens coniunctio est idonea mixtura in potestate colitis experimentalis et in iudicio esse debet. ad occasum orci.


  • Previous:
  • Deinde:

  • Close

    2,3,5-Triphenyl-2H-tetrazolium chloridum Cas: 298-96-4 98% Off-album / pallide flavo pulveris crystallini